News

NMR in Target Driven Drug Discovery: Why Not?

NMR is a powerful and information rich tool that can provide critical information at many stages of the pre-clinical drug discovery process.
In a recent publication ZoBio scientists discuss a number of examples…

Mirati and ZoBio Collaborate to Advance Targeted Oncology Programs

Mirati Therapeutics has selected ZoBio to provide fragment-based screening, biophysical compound characterization and structural biology for several oncology targets. In this arrangement, ZoBio screens its fragment library using both its proprietary Target Immobilized NMR Screening and SPR capabilities…